Intera Oncology
Wellesley
About Intera Oncology
Intera Oncology specializes in improving the survival of colorectal cancer and cholangiocarcinoma patients. It acquires Oncology and Neuromodulation Drug Delivery products from Johnson & Johnson where they entered an agreement for the sale of the Drug Delivery Oncology/Neuromodulation business to Intera Oncology. This includes accessories for Codman 3000, MedStream, and Model 400/500 pumps. It was founded in 2019 and is headquartered in Wellesley, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: M&A
- Last round: Seed (Aug 2021)
- Website: interaoncology.com
- Phone: (781) 489-5724
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device, Oncology
Social Profiles
Canonical: https://fsome.com/organization/intera-oncology-4462 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.